LONDON, Oct. 7, 2015 /PRNewswire/ -- About female contraceptive
Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.
Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.
This report covers the following types of female contraceptive:
Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)
Drugs (Birth control pills and Emergency pills)
Technavio's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
AllerganMerckPfizerTeva Pharmaceutical
Other prominent vendors
Ansell
Church & Dwight
Bayer
Agile Therapeutics
Caya
Fuji Latex
Janssen Pharmaceuticals
HLL Lifecare
Lipocine
Mayer Laboratories
Okamoto Industries
Reckitt Benckiser Group
Today Sponge
Female Health
Key market driver
Improved family planningFor a full, detailed list, view our reportKey market challenge
Lack of social acceptance
For a full, detailed list, view our report
Key market trend
Increased unplanned pregnancyFor a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Download the full report: https://www.reportbuyer.com/product/3312099/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article